These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5003854)

  • 1. [Mycobacterial resistance to ethambutol].
    Battaglia B
    Lotta Tuberc; 1971; 41(3):397-400. PubMed ID: 5003854
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ethambutol-sensitivity of mycobacteria].
    Lucchesi M; Termine A; Mancini P
    Ann Ist Carlo Forlanini; 1969; 29(1):51-9. PubMed ID: 4996682
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effectiveness of ethambutol in chronic pulmonary tuberculosis].
    Golli V; Stefanin E; Chiper P; Stefănescu I; Popescu-Crivina IM; Anghel E; Kosinski E; Daha A; Kosinski M; Floricel N
    Ftiziologia; 1972; 21(5):489-94. PubMed ID: 4632131
    [No Abstract]   [Full Text] [Related]  

  • 4. [Dynamics of rifampicin and ethambutol resistance of strains of Koch bacilli isolated from patients with pulmonary tuberculosis 1973-1981].
    Ionescu C; Timoşca S; Petreanu V; Petreanu C; Georgescu M; Martinescu T
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):315-20. PubMed ID: 6304845
    [No Abstract]   [Full Text] [Related]  

  • 5. [Early results of ethambutol treatment in patients with cavernous pulmonary tuberculosis and resistance to many antitubercular agents].
    Kamińska M; Czajka-Kropaczek L; Ciechanowska A
    Gruzlica; 1971 Jul; 39(7):648-52. PubMed ID: 5000657
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ethambutol in the treatment of chronic pulmonary tuberculosis in patients excreting organisms resistant to several antitubercular agents].
    Bek-Lissner E; Rózewska M
    Gruzlica; 1971 Jul; 39(7):643-7. PubMed ID: 5000656
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ethambutol in the treatment of chronic pulmonary tuberculosis with bacilli resistant to tuberculostatics].
    Anastasatu C; Kaufman S; Barcan F; Gheorghiu M; Cristea M; Ulpian C; Iancovici O
    Ftiziologia; 1971; 20(4):373-9. PubMed ID: 5005706
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical and bacteriological experimentation with a new antitubercular chemotherapeutic agent: ethambutol].
    Serra C; Andreis G
    G Ital Chemioter; 1966; 13(1):109-27. PubMed ID: 4967318
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of ethambutol in clinical practice.
    Jancik E
    Tubercle; 1969 Mar; 50():Suppl:52-4. PubMed ID: 4918613
    [No Abstract]   [Full Text] [Related]  

  • 10. Niacin-negative Mycobacterium tuberculosis.
    Tsukamura M
    Am Rev Respir Dis; 1974 Jul; 110(1):101-3. PubMed ID: 4209362
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
    Negi SS; Gupta S; Lal S
    J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experience with long-term application of ethambutol in ambulatory and hospitalized patients with chronic destructive tuberculosis of the lungs].
    Rudoi NM; Eisaev BA
    Probl Tuberk; 1973; 51(1):42-6. PubMed ID: 4199376
    [No Abstract]   [Full Text] [Related]  

  • 13. [Criteria of clinical resistance of cycloserine, ethionamide and ethambutol].
    Okamoto K; Watanabe S; Terunuma K
    Kekkaku; 1970 Feb; 45(2):65-72. PubMed ID: 4985702
    [No Abstract]   [Full Text] [Related]  

  • 14. [Bacteriostatic activity of the blood in pulmonary tuberculosis and its clinical significance].
    Alekseenko AM
    Probl Tuberk; 1979 Jan; (1):33-7. PubMed ID: 105352
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug resistance to the first line of antitubercular regimen (a preliminary report).
    Varaiya A; Gogate A
    Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-course treatment regimens for patients with tuberculosis.
    Dutt AK; Stead WW
    Arch Intern Med; 1980 Jun; 140(6):827-9. PubMed ID: 6770770
    [No Abstract]   [Full Text] [Related]  

  • 17. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing.
    Laszlo A; Rahman M; Raviglione M; Bustreo F
    Int J Tuberc Lung Dis; 1997 Jun; 1(3):231-8. PubMed ID: 9432369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in the primary resistance to Mycobacterium tuberculosis in Piedmont 1965-1979].
    Giorgis GE; Moschini MT; Bardessono F; Amelio M
    Minerva Med; 1981 Jun; 72(25):1581-6. PubMed ID: 6789249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results and therapeutic consequences of general resistance tests in tuberculosis of the urogenital system (author's transl).
    Gabler A
    Med Klin; 1973 Dec; 68(50):4648-52. PubMed ID: 4131488
    [No Abstract]   [Full Text] [Related]  

  • 20. [Biological properties of Mycobacterium tuberculosis in relation to sensitivity to antibacterial preparations].
    Gol'shevskaia VI; Grishina TA; Karpenko OL; Safonova SG; Grishina TD
    Probl Tuberk; 1995; (4):37-40. PubMed ID: 7567869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.